Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application

Tulay Irez; Onur Güralp; Hakan Yelke; Semra Kahraman

doi:doi:10.11648/j.abb.20210903.14

| Peer-Reviewed

Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application

Tulay Irez, Onur Güralp, Hakan Yelke, Semra Kahraman

Published in Advances in Bioscience and Bioengineering (Volume 9, Issue 3)

Received: 7 August 2021 Accepted: 20 August 2021 Published: 10 September 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Aim: Failed fertilization (FF) occurs in approximately 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. The reasons of total fertilization insufficiency in ICSI applications can be listed as mitosis errors, sperm aster formation defects, sperm decondensation defects, PN formation defects and oocyte activation defects. In this study, sperm functions, oocyte morphology, hormone levels and possible effects of gonadotropins used in the treatment were investigated retrospectively. Material and Methods: In this study, semen parameters and sperm functions, oocyte morphology, basal hormone values and treatment processes of 32 fertilization failure cases and 91 fertile controls were compared. Results: It was found that age of female and male, basal FSH value and gonadotropin used in the treatment process were higher in total fertilization failure cases compared to fertile controls (p = 0.004, p = 0.041, p = 0.008, p = 0.004). Basal AMH level, total oocyte count, M2 oocyte count, quality oocyte count and normal ZP percentage were lower in fertilization failure cases (p = 0.002, p = 0.000, p = 0.000, p = 0.008, p = 0.000). There was no statistically significant difference between the two groups in terms of sperm functions. Conclusions: It was understood that high FSH and low AMH levels and high-dose gonadotropin treatment in cases with optimal sperm quality may cause oocyte cytoplasmic and zona pellucida abnormalities, and it should be discussed as a cause of fertilization failure.

Published in	Advances in Bioscience and Bioengineering (Volume 9, Issue 3)
DOI	10.11648/j.abb.20210903.14
Page(s)	87-91
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Antimullerian Hormone, Oocyte Abnormalities, Fertilization Failure

References

[1]	Tesarik, J., Junca, A. M., Hazout, A., Aubriot, F. X., Nathan, C., Cohen-Bacrie, P. and Dumont-Hassan, M. (2000) Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum. Reprod., 15, 1396–1399.
[2]	Ben-Yosef D, Shalgi R. Oocyte activation: lessons from human infertility. Trends Mol Med. 2001 Apr; 7 (4): 163-9. doi: 10.1016/s1471-4914 (01)01957-8. PMID: 11286940.
[3]	Tesarik J, Rienzi L, Ubaldi F, Mendoza C and Greco E. Use of a modified intracytoplasmic sperm injection technique to overcome sperm-borne oocyte activation failures. Fertil Steril, 2002, 78, 619–624.
[4]	Torra-Massana M, Cornet-Bartolomé D, Barragán M, Durban M, Ferrer-Vaquer A, Zambelli F, Rodriguez A, Oliva R, Vassena R. Novel phospholipase C zeta 1 mutations associated with fertilization failures after ICSI. Hum Reprod. 2019, 1; 34 (8): 1494-1504. doi: 10.1093 /humrep/dez094.
[5]	Modarres P, Tavalaee M, Ghaedi K, Nasr-Esfahani MH. An Overview of The Globozoospermia as A Multigenic Identified Syndrome. Int J Fertil Steril. 2019; 12 (4): 273-277. doi: 10.22074/ijfs.2019.5561. Epub 2018 Oct 2.
[6]	Zhang Y, Shao L, Xu Y, Cui Y, Liu J, et al. Effect of Anti-Mullerian Hormone in Culture Medium on Quality of Mouse Oocytes Matured In Vitro. PLoS ONE, 2014, 9 (6): e99393. doi: 10.1371/journal.pone.0099393.
[7]	Irez T., Ocal P., Guralp O., Cetin M., Aydogan B., Sahmay S. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. Arch Gynecol Obstet. 2011; 284 (5): 1295-301. doi: 10.1007/s00404-011-1979-6. Epub 2011 Jul 12.
[8]	Tesarik J, Sousa M, Testart J. Human oocyte activation after intracytoplasmic sperm injection. Hum Reprod. 1994 Mar; 9 (3): 511-8. doi: 10.1093/oxfordjournals.humrep.a138537. Erratum in: Hum Reprod 1994 May; 9 (5): 968. PMID: 8006144.
[9]	Dozortsev D, Rybouchkin A, De Sutter P, Qian C, Dhont M. Human oocyte activation following intracytoplasmic injection: the role of the sperm cell. Hum Reprod. 1995 Feb; 10 (2): 403-7. doi: 10.1093/oxfordjournals.humrep.a135952. PMID: 7769071.
[10]	Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod. 1999 Feb; 14 (2): 354-8. doi: 10.1093/humrep/14.2.354. PMID: 10099978.
[11]	Jiaen Liu, Zsolt Nagy, Hubert Joris, Herman Tournaye, Paul Devroey, André Van Steirteghem, Andrology: Successful fertilization and establishment of pregnancies after intracytoplasmic sperm injection in patients with globozoospermia, Human Reproduction, Volume 10, Issue 3, March 1995, Pages 626–629, https://doi.org/10.1093/oxfordjournals.humrep.a136000.
[12]	Niakan KK, Han J, Pedersen RA, Simon C, Pera RA. Human pre-implantation embryo development. Development. 2012; 139 (5): 829-841. doi: 10.1242/dev.060426.
[13]	Seidler, E., Murphy, L., Vaughan, D., & Sakkas, D. (2019). Fertilization and Complete Fertilization Failure in Human IVF. In G. Kovacs, A. Rutherford, & D. Gardner (Eds.), How to Prepare the Egg and Embryo to Maximize IVF Success (pp. 224-231). Cambridge: Cambridge University Press. doi: 10.1017/9781316756744.019.
[14]	Swain JE, Pool TB. ART failure: oocyte contributions to unsuccessful fertilization. Hum Reprod Update. 2008 Sep-Oct; 14 (5): 431-46. doi: 10.1093/humupd/dmn025. Epub 2008 Jul 5. PMID: 18603645.
[15]	Heindryckx B., Elst J. V., Sutter P. D., Dhont M. Treatment option for sperm- or oocyte-related fertilization failure: assisted oocyte activation following diagnostic heterologous ICSI. Human Reproduction, 2005, 20, (8), 2237–2241.
[16]	Meerschaut F. V., Nikiforaki D., Heindryckxlow B. Assisted oocyte activation following ICSI fertilization failure. RBMOnline 2014, 28 (5): 560–571.
[17]	Neri Q. V., Lee B., Rosenwaks Z., Machaca K., Palermo G. D. Understanding fertilization through intracytoplasmic sperm injection (ICSI) Cell Calcium, 2014, 55 (1), 24-37.
[18]	Vanderheyden V., Wakaib T. Bultynck G., De Smedt H.,. Parysa J. B., Fissore R. A. Regulation of inositol 1,4,5-trisphosphate receptor type 1 function during oocyte maturation by MPM-2 phosphorylation. Cell Calcium Volume 46, Issue 1, July 2009, Pages 56-64.
[19]	Goud P, Goud A, Van Oostveldt P, Van der Elst J, Dhont M. Fertilization abnormalities and pronucleus size asynchrony after intracytoplasmic sperm injection are related to oocyte postmaturity. Fertil Steril. 1999 Aug; 72 (2): 245-52. doi: 10.1016/s0015-0282 (99)00231-9. PMID: 10438989.
[20]	Combelles CM, Morozumi K, Yanagimachi R, Zhu L, Fox JH, Racowsky C. Diagnosing cellular defects in an unexplained case of total fertilization failure. Hum Reprod. 2010 Jul; 25 (7): 1666-71. doi: 10.1093/humrep/deq064. Epub 2010 May 15. PMID: 20472911.
[21]	Kovacic B, Vlaisavljević V. Influence of atmospheric versus reduced oxygen concentration on development of uman blastocysts in vitro: a prospective study on sibling oocytes. Reprod Biomed Online. 2008 Aug; 17 (2): 229-36. doi: 10.1016/s1472-6483 (10)60199-x. PMID: 18681997.
[22]	Shahrokhi SZ, Kazerouni F, Ghaffari F. Anti-Müllerian Hormone: genetic and environmental effects. Clin Chim Acta 2018; 476: 123–129.
[23]	Lie Fong S, Visser JA, Welt CK, et al. Serum anti-Müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 2012; 97: 4650–4655.
[24]	Tolikas A, Tsakos E, Gerou S, et al. Anti-Müllerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles. Hum Fertil 2011; 14 (4): 246–253.
[25]	Borges E., Braga D. P. A. F., Setti A., Figueira R. C., and Iaconelli A. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation. JBRA Assist Reprod. 2017; 21 (3): 176–182. doi: 10.5935/1518-0557.20170035 PMCID: PMC5574637 PMID: 28837024.
[26]	Catteau-Jonard S, Jamin SP, Leclerc A, et al. Anti-Müllerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93 (11): 4456–4461.
[27]	Kedem-Dickman A, Maman E, Yung Y, et al. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes. Reprod Biomed Online 2012; 24: 540–546.
[28]	Gupta S., Karuputhula N. B., Kumar N., Srivastava A., Singh B., Dubey K. Correlation of basal serum anti-Mullerian hormone level with oocyte quality and embryo development potential in women undergoing IVF-ICSI. Fertility Science and Research, 2017, 4, 2, 112-116.
[29]	Velásquez A., Mellisho E., Ovidio F. C., Rodríguez-Álvarez L. Effect of BMP15 and/or AMH during in vitro maturation of oocytes from involuntarily culled dairy cows. Molecular Reproduction and Development, 2019, 86, 2, 209-223, https://doi.org/10.1002/mrd.23096
[30]	Fang T., Su Z., Wang L., Yuan P., Li R., Ouyang N., Zheng L., and Wang W. Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function Reprod Biol Endocrinol. 2015; 13: 63. Published online 2015 Jun 17. doi: 10.1186/s12958-015-0056-6 PMCID: PMC4470037 PMID: 26082101 DOI 10.1186/s12958-015-0056-6.
[31]	Barad DH, Weghofer A, Gleicher N Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol. 2007; 109 (6): 1404-10.
[32]	Borges E, Braga DPAF, Setti A, Figueira RC, Iaconelli A Jr. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation. JBRA Assist Reprod. 2017; 21 (3): 176-182. Published 2017 Sep 1. doi: 10.5935/1518-0557.20170035.
[33]	Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod. 2004 Apr; 19 (4): 893-8. doi: 10.1093/humrep/deh141. Epub 2004 Mar 11. PMID: 15016786.
[34]	Sauerbrun-Cutler MT, Vega M., Breborowicz A., Gonzales E., Stein D., Lederman M., and Keltz M. Oocyte zona pellucida dysmorphology is associated with diminished in-vitro fertilization success. J Ovarian Res. 2015; 8: 5. Published online 2015 Feb 27. doi: 10.1186/s13048-014-0111-5 PMCID: PMC4355133 PMID: 25823613.
[35]	Xu H. Deng K. Luo Q. Chen J. Zhang X. Wang X. Diao H. ZhangC. High Serum FSH is Associated with Brown Oocyte Formation and a Lower Pregnacy Rate in Human IVF Parctice Cellular Physiology and Biochemistry 2016; 39: 677-684 https://doi.org/10.1159/000445658
[36]	Rienzi L, Vajta G, Ubaldi F: Predictive value of oocyte morphology in human IVF: a systematic review of the literature. Hum Reprod Update 2011; 17: 34-45.
[37]	Alikani M, Palermo G, Adler A, Bertoli M, Blake M, Cohen J: Intracytoplasmic sperm injection in dysmorphic human oocytes. Zygote 1995; 3: 283-288.
[38]	Ten J, Mendiola J, Vioque J, de Juan J, Bernabeu R: Donor oocyte dysmorphisms and their influence on fertilization and embryo quality. Reprod Biomed Online 2007; 14: 40-48.
[39]	Rienzi L, Balaban B, Ebner T, Mandelbaum J: The oocyte. Hum Reprod 2012; 27: 12-21.
[40]	Van Blerkom J, Henry G: Oocyte dysmorphism and aneuploidy in meiotically mature human oocytes after ovarian stimulation. Hum Reprod 1992; 7: 379-390.

Cite This Article

Plain Text BibTeX RIS

APA Style

Tulay Irez, Onur Güralp, Hakan Yelke, Semra Kahraman. (2021). Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Advances in Bioscience and Bioengineering, 9(3), 87-91. https://doi.org/10.11648/j.abb.20210903.14

Copy | Download

ACS Style

Tulay Irez; Onur Güralp; Hakan Yelke; Semra Kahraman. Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Adv. BioSci. Bioeng. 2021, 9(3), 87-91. doi: 10.11648/j.abb.20210903.14

Copy | Download

AMA Style

Tulay Irez, Onur Güralp, Hakan Yelke, Semra Kahraman. Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Adv BioSci Bioeng. 2021;9(3):87-91. doi: 10.11648/j.abb.20210903.14

Copy | Download

@article{10.11648/j.abb.20210903.14,
  author = {Tulay Irez and Onur Güralp and Hakan Yelke and Semra Kahraman},
  title = {Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application},
  journal = {Advances in Bioscience and Bioengineering},
  volume = {9},
  number = {3},
  pages = {87-91},
  doi = {10.11648/j.abb.20210903.14},
  url = {https://doi.org/10.11648/j.abb.20210903.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210903.14},
  abstract = {Aim: Failed fertilization (FF) occurs in approximately 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. The reasons of total fertilization insufficiency in ICSI applications can be listed as mitosis errors, sperm aster formation defects, sperm decondensation defects, PN formation defects and oocyte activation defects. In this study, sperm functions, oocyte morphology, hormone levels and possible effects of gonadotropins used in the treatment were investigated retrospectively. Material and Methods: In this study, semen parameters and sperm functions, oocyte morphology, basal hormone values and treatment processes of 32 fertilization failure cases and 91 fertile controls were compared. Results: It was found that age of female and male, basal FSH value and gonadotropin used in the treatment process were higher in total fertilization failure cases compared to fertile controls (p = 0.004, p = 0.041, p = 0.008, p = 0.004). Basal AMH level, total oocyte count, M2 oocyte count, quality oocyte count and normal ZP percentage were lower in fertilization failure cases (p = 0.002, p = 0.000, p = 0.000, p = 0.008, p = 0.000). There was no statistically significant difference between the two groups in terms of sperm functions. Conclusions: It was understood that high FSH and low AMH levels and high-dose gonadotropin treatment in cases with optimal sperm quality may cause oocyte cytoplasmic and zona pellucida abnormalities, and it should be discussed as a cause of fertilization failure.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application
AU  - Tulay Irez
AU  - Onur Güralp
AU  - Hakan Yelke
AU  - Semra Kahraman
Y1  - 2021/09/10
PY  - 2021
N1  - https://doi.org/10.11648/j.abb.20210903.14
DO  - 10.11648/j.abb.20210903.14
T2  - Advances in Bioscience and Bioengineering
JF  - Advances in Bioscience and Bioengineering
JO  - Advances in Bioscience and Bioengineering
SP  - 87
EP  - 91
PB  - Science Publishing Group
SN  - 2330-4162
UR  - https://doi.org/10.11648/j.abb.20210903.14
AB  - Aim: Failed fertilization (FF) occurs in approximately 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. The reasons of total fertilization insufficiency in ICSI applications can be listed as mitosis errors, sperm aster formation defects, sperm decondensation defects, PN formation defects and oocyte activation defects. In this study, sperm functions, oocyte morphology, hormone levels and possible effects of gonadotropins used in the treatment were investigated retrospectively. Material and Methods: In this study, semen parameters and sperm functions, oocyte morphology, basal hormone values and treatment processes of 32 fertilization failure cases and 91 fertile controls were compared. Results: It was found that age of female and male, basal FSH value and gonadotropin used in the treatment process were higher in total fertilization failure cases compared to fertile controls (p = 0.004, p = 0.041, p = 0.008, p = 0.004). Basal AMH level, total oocyte count, M2 oocyte count, quality oocyte count and normal ZP percentage were lower in fertilization failure cases (p = 0.002, p = 0.000, p = 0.000, p = 0.008, p = 0.000). There was no statistically significant difference between the two groups in terms of sperm functions. Conclusions: It was understood that high FSH and low AMH levels and high-dose gonadotropin treatment in cases with optimal sperm quality may cause oocyte cytoplasmic and zona pellucida abnormalities, and it should be discussed as a cause of fertilization failure.
VL  - 9
IS  - 3
ER  -

Copy | Download

Author Information

Tulay Irez

Department of Histology and Embryology, Medical Faculty, Istanbul Yeni Yuzyil University, Istanbul, Turkey
Onur Güralp

Department of Gynaecology& Obstetrics, Medical Faculty, University of Oldenburg, Oldenburg, Germany
Hakan Yelke

Department of IVF and Gynetics Center, Sisli Memorial Hospital, Istanbul, Turkey
Semra Kahraman

Department of Gynecology and Obstetrics and IVF and Gynetics Center, Sisli Memorial Hospital, Istanbul, Turkey

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Tulay Irez, Onur Güralp, Hakan Yelke, Semra Kahraman. (2021). Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Advances in Bioscience and Bioengineering, 9(3), 87-91. https://doi.org/10.11648/j.abb.20210903.14

Copy | Download

ACS Style

Tulay Irez; Onur Güralp; Hakan Yelke; Semra Kahraman. Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Adv. BioSci. Bioeng. 2021, 9(3), 87-91. doi: 10.11648/j.abb.20210903.14

Copy | Download

AMA Style

Tulay Irez, Onur Güralp, Hakan Yelke, Semra Kahraman. Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application. Adv BioSci Bioeng. 2021;9(3):87-91. doi: 10.11648/j.abb.20210903.14

Copy | Download

@article{10.11648/j.abb.20210903.14,
  author = {Tulay Irez and Onur Güralp and Hakan Yelke and Semra Kahraman},
  title = {Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application},
  journal = {Advances in Bioscience and Bioengineering},
  volume = {9},
  number = {3},
  pages = {87-91},
  doi = {10.11648/j.abb.20210903.14},
  url = {https://doi.org/10.11648/j.abb.20210903.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210903.14},
  abstract = {Aim: Failed fertilization (FF) occurs in approximately 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. The reasons of total fertilization insufficiency in ICSI applications can be listed as mitosis errors, sperm aster formation defects, sperm decondensation defects, PN formation defects and oocyte activation defects. In this study, sperm functions, oocyte morphology, hormone levels and possible effects of gonadotropins used in the treatment were investigated retrospectively. Material and Methods: In this study, semen parameters and sperm functions, oocyte morphology, basal hormone values and treatment processes of 32 fertilization failure cases and 91 fertile controls were compared. Results: It was found that age of female and male, basal FSH value and gonadotropin used in the treatment process were higher in total fertilization failure cases compared to fertile controls (p = 0.004, p = 0.041, p = 0.008, p = 0.004). Basal AMH level, total oocyte count, M2 oocyte count, quality oocyte count and normal ZP percentage were lower in fertilization failure cases (p = 0.002, p = 0.000, p = 0.000, p = 0.008, p = 0.000). There was no statistically significant difference between the two groups in terms of sperm functions. Conclusions: It was understood that high FSH and low AMH levels and high-dose gonadotropin treatment in cases with optimal sperm quality may cause oocyte cytoplasmic and zona pellucida abnormalities, and it should be discussed as a cause of fertilization failure.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Could Antimullerian Hormone Play a Role in Fertilization Failure in ICSI Application
AU  - Tulay Irez
AU  - Onur Güralp
AU  - Hakan Yelke
AU  - Semra Kahraman
Y1  - 2021/09/10
PY  - 2021
N1  - https://doi.org/10.11648/j.abb.20210903.14
DO  - 10.11648/j.abb.20210903.14
T2  - Advances in Bioscience and Bioengineering
JF  - Advances in Bioscience and Bioengineering
JO  - Advances in Bioscience and Bioengineering
SP  - 87
EP  - 91
PB  - Science Publishing Group
SN  - 2330-4162
UR  - https://doi.org/10.11648/j.abb.20210903.14
AB  - Aim: Failed fertilization (FF) occurs in approximately 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. The reasons of total fertilization insufficiency in ICSI applications can be listed as mitosis errors, sperm aster formation defects, sperm decondensation defects, PN formation defects and oocyte activation defects. In this study, sperm functions, oocyte morphology, hormone levels and possible effects of gonadotropins used in the treatment were investigated retrospectively. Material and Methods: In this study, semen parameters and sperm functions, oocyte morphology, basal hormone values and treatment processes of 32 fertilization failure cases and 91 fertile controls were compared. Results: It was found that age of female and male, basal FSH value and gonadotropin used in the treatment process were higher in total fertilization failure cases compared to fertile controls (p = 0.004, p = 0.041, p = 0.008, p = 0.004). Basal AMH level, total oocyte count, M2 oocyte count, quality oocyte count and normal ZP percentage were lower in fertilization failure cases (p = 0.002, p = 0.000, p = 0.000, p = 0.008, p = 0.000). There was no statistically significant difference between the two groups in terms of sperm functions. Conclusions: It was understood that high FSH and low AMH levels and high-dose gonadotropin treatment in cases with optimal sperm quality may cause oocyte cytoplasmic and zona pellucida abnormalities, and it should be discussed as a cause of fertilization failure.
VL  - 9
IS  - 3
ER  -

Copy | Download